Concepedia

Publication | Open Access

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study

23

Citations

23

References

2020

Year

Abstract

Compared with sorafenib, apatinib yielded comparable PFS and OS, and even better ORR, in patients with advanced HCC.

References

YearCitations

Page 1